1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global Oncology Drugs Market, By Drug Type, By Therapy, By Drug Therapy, By Route of Administration, By Gender, By Cancer Type, By Distribution Channel, By Region, Competition, Forecast & Opportunities, 2025

Global Oncology Drugs Market, By Drug Type, By Therapy, By Drug Therapy, By Route of Administration, By Gender, By Cancer Type, By Distribution Channel, By Region, Competition, Forecast & Opportunities, 2025

  • April 2020
  • 117 pages
  • ID: 5885386
  • Format: PDF
  • TechSci Research


Table of Contents

Global Oncology Drugs Market, By Drug Type (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), By Drug Therapy (Adjuvant, Neoadjuvant and Concurrent), By Route of Administration (Oral, Intravenous, Subcutaneous, Others), By Gender (Male, Female), By Cancer Type (Lung Cancer, Stomach Cancer, Others), By Distribution Channel (Hospital Pharmacies, Others), By Region, Competition, Forecast & Opportunities, 2025

Global oncology drugs market is projected to grow at a brisk rate over the forecast period owing to widespread prevalence of cancer, globally.Various other related factors which are contributing to the growth of oncology drugs market include rise in geriatric population worldwide, increase in global healthcare expenditure, rising number of product approvals by regulatory bodies and growing R&D activities for the development of new cancer drugs.

Furthermore, emergence of biosimilar products for cancer treatment, increasing collaborations between pharmaceutical companies and development of pipeline oncology products are providing opportunities for various oncology drug manufacturers.

Oncology includes diagnosis, prevention and treatment of cancer diseases.Oncology or anti-cancer drugs can be used alone or in combination to control or destroy neoplastic cells.

These drugs have the capacity to treat various kinds of cancers including blood cancer, liver cancer, bone cancer and breast cancer.

However, the oncology drug market also faces some restrains. Fatal effects associated with the use of cancer drugs and high cost of the drug & development process are proving a hindrance for the growth of oncology drugs market.

The global oncology drugs market is segmented based on drug type, therapy, drug therapy, route of administration, gender, cancer type, distribution channel, and region.Based on therapy, the market is segmented into chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others.

The chemotherapy segment holds the largest market share in global oncology drugs market owing to its ability to kill cancer cells, higher efficacy and higher survival rates. However, the immunotherapy segment is going to witness fastest growth during the forecast period as they do not harm other living cells of the body.

Based on cancer type, the lung cancer segment holds the largest share in the global oncology drugs market due to its considerable surge in prevalence across the world. Major players operating in the global oncology drugs market are AbbVie Inc, Roche Holding AG, Novartis International AG, Johnson & Johnson, Bristol-Myers Squibb Company, Celgene Corporation, Merck & Co., Inc, Pfizer Inc., Eli Lilly, AstraZeneca PLC, Takeda Pharmaceutical, Amgen, Astellas Pharma, Sanofi, Eisai, Abbott, Thermo Fisher Scientific, Astex Pharmaceutical, Daiichi Sankyo, Teva Pharmaceutical and others.

Years considered for this report:

Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025

Objective of the Study:

• To analyze and forecast the market size of global oncology drugs market.
• To classify and forecast global oncology drugs market based on drug type, therapy, drug therapy, route of administration, gender, cancer type, distribution channel, company and regional distribution.
• To identify drivers and challenges for global oncology drugs market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global oncology drugs market.
• To conduct pricing analysis for global oncology drugs market.
• To identify and analyze the profile of leading players operating in global oncology drugs market.
The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of oncology drug companies across the globe.

Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.

The analyst examined the presence of all major players across the globe.
The analyst calculated the market size of global oncology drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and drug therapies for getting an appropriate, overall market size.

Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:

• Oncology drugs companies and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to oncology drugs
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global oncology drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Market, By Drug Type:
o Cytotoxic Drugs
o Targeted Drugs
o Hormonal Drugs
• Market, By Therapy:
o Chemotherapy
o Targeted Therapy
o Immunotherapy (Biologic Therapy)
o Hormonal Therapy
o Others
• Market, By Drug Therapy:
o Adjuvant
o Neoadjuvant
o Concurrent
• Market, By Route of Administration:
o Oral
o Intravenous
o Subcutaneous
o Others
• Market, By Gender:
o Male
o Female
• Market, By Cancer Type:
o Lung Cancer
o Stomach Cancer
o Colorectal Cancer
o Breast Cancer
o Prostate Cancer
o Liver Cancer
o Esophagus Cancer
o Cervical Cancer
o Kidney Cancer
o Bladder Cancer
o Others
• Market, By Distribution Channel:
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
o Government Hospitals
• Market, By Region:
o Asia-Pacific
o Europe
o North America
o South America
o Middle East

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global oncology drugs market.

Available Customizations:

With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on